How to use anti-CXCL13 antibody and it

Title:

How to use anti-CXCL13 antibody and it

Document Type and Number:

Japanese Patent JP6097690

Kind Code:

B2

Abstract:

Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.

More Like This:

WO1999018801	METHODS AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASE USING HEAT SHOCK PROTEINS
WO/2018/031424	IN VIVO METHODS FOR SELECTING PEPTIDES THAT CROSS THE BLOOD BRAIN BARRIER, RELATED COMPOSITIONS AND METHODS OF USE
WO/2005/049825	METHOD OF DETECTING SIGNAL TRANSDUCTION BY G PROTEIN-COUPLED RECEPTOR USING GERMINATION BACULOVIRUS

Inventors:

Klimachewa, Ekaterina
Paris mark
Smith, Ernest S

Application Number:

JP2013527309A

Publication Date:

March 15, 2017

Filing Date:

September 01, 2011

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Vaxinex, Inc.

International Classes:

C12N15/09; A61K39/395; A61P1/04; A61P19/02; A61P29/00; A61P35/00; A61P37/00; A61P37/02; C07K16/18; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/08

Domestic Patent References:

JP2010519280A
JP2010523580A
JP2009534419A

Foreign References:

WO2008079361A1

Attorney, Agent or Firm:

Shoichi Okuyama
Arihara Koichi
Matsushima Tetsuo
Hidefumi Kawamura
Ayako Nakamura
Satoshi Morimoto
Akiko Mizushima

Previous Patent: A method and a device for preventing rain out

Next Patent: JPS6097691